Cytosorbents Corporation (CTSO)

NASDAQ: CTSO · Real-Time Price · USD

0.3772

-0.0227 (-5.68%)

At close: Aug 17, 2026, 4:00 PM EDT

0.385349

+0.0081 (2.16%)

After-hours: Aug 17, 2026, 7:46 PM EDT

Cytosorbents Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	37.22	37.06	35.6	31.08	34.69	43.17
Revenue	37.22	37.06	35.6	31.08	34.69	43.17
Revenue Growth	3.07%	4.12%	14.51%	-10.39%	-19.64%	5.27%
Cost of Revenue	10.57	10.57	10.71	9.13	13.96	11.05
Gross Profit	26.65	26.49	24.89	21.95	20.73	32.12
Selling, General & Admin	33.78	35.65	33.73	38.31	36.5	38.48
Research & Development	4.64	5.09	7.61	15.59	15.12	16.38
Operating Expenses	38.42	40.73	41.34	53.9	51.62	54.86
Operating Income	-11.77	-14.24	-16.45	-31.95	-30.89	-22.74
Interest Expense	-3.12	-2.61	-1.4	-0.16	-	-
Interest & Investment Income	-	-	-	-	0.13	0.03
Currency Exchange Gain (Loss)	-2.01	9.32	-4.23	1.95	-2.45	-2.58
Other Non Operating Income (Expenses)	-	-	-	0.1	-0.07	-
EBT Excluding Unusual Items	-16.9	-7.53	-22.08	-30.06	-33.27	-25.29
Merger & Restructuring Charges	-0.82	-0.51	-	-	-	-
Asset Writedown	-0.9	-0.56	-0.33	-	-0.64	-
Pretax Income	-18.62	-8.6	-22.41	-30.06	-33.91	-25.29
Income Tax Expense	-0.4	-0.4	-1.69	-0.81	-1.09	-0.74
Net Income	-18.21	-8.2	-20.72	-29.25	-32.81	-24.56
Net Income to Common	-18.21	-8.2	-20.72	-29.25	-32.81	-24.56
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	63	62	54	45	44	43
Shares Outstanding (Diluted)	63	62	54	45	44	43
Shares Change	8.00%	14.32%	21.90%	2.49%	0.49%	11.70%
EPS (Basic)	-0.29	-0.13	-0.38	-0.65	-0.75	-0.57
EPS (Diluted)	-0.29	-0.13	-0.38	-0.65	-0.75	-0.57
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-9.3	-12.54	-14.71	-22.19	-34.32	-17.65
Free Cash Flow Per Share	-0.15	-0.20	-0.27	-0.50	-0.79	-0.41
Gross Margin	71.61%	71.47%	69.92%	70.62%	59.77%	74.41%
Operating Margin	-31.63%	-38.42%	-46.22%	-102.78%	-89.04%	-52.69%
Profit Margin	-48.94%	-22.12%	-58.21%	-94.09%	-94.59%	-56.89%
Free Cash Flow Margin	-24.98%	-33.84%	-41.33%	-71.39%	-98.94%	-40.88%
EBITDA	-10.35	-12.74	-14.88	-30.49	-30	-22.01
EBITDA Margin	-27.81%	-34.38%	-41.81%	-98.08%	-86.49%	-51.00%
D&A For EBITDA	1.42	1.5	1.57	1.46	0.88	0.73
EBIT	-11.77	-14.24	-16.45	-31.95	-30.89	-22.74
EBIT Margin	-31.63%	-38.42%	-46.22%	-102.78%	-89.04%	-52.69%
Revenue as Reported	-	-	-	-	34.69	43.17
Advertising Expenses	-	0.3	0.3	-	0.58	0.62

SEC Filings: 10-K · 10-Q